Binding Sites for Alpha-trinositol (inositol 1,2,6-trisphosphate) in Porcine Tissues; Comparison with Ins(1,4,5)P3 and Ins(1,3,4,5)P4-binding Sites

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1996 Mar 1

PMID 8851511

Citations 1

Authors

R Stricker

E Westerberg

G Reiser

Affiliations

Soon will be listed here.

Abstract

1. The molecular mechanism of action of the inositol trisphosphate isomer, alpha-trinositol (Ins(1,2,6)P3) which has potential therapeutic use in treatment of inflammation and burn oedema, is still unclear. Therefore we have studied binding sites for alpha-trinositol in different tissues. 2. In membranes from pig cerebellum, liver, kidney, heart, and spleen, the density of specific [3]-alpha-trinositol binding sites was maximal at pH 5.0. Cerebellum and spleen showed only one binding site (cerebellum KD = 9.1 microM, spleen KD = 7.3 microM). In the other tissues, there were a high-affinity site (heart KD = 70 nM, liver KD = 790 nM and kidney KD = 1800 nM), besides a low-affinity site with a KD ranging between 32 and 120 microM. In cerebellar membranes, the affinity and density (107 pmol mg-1 protein) of alpha-trinositol binding sites were not affected by phosphate (0 to 25 mM). 3. Binding of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 to membranes from different porcine tissues was also determined. Ins(1,3,4,5)P4, the isomer stereochemically related to alpha-trinositol, binds with an affinity of 1.2 nM in cerebellum, but in the other tissues the binding site density was too low to determine the affinity. With cerebellar membranes heterologous displacement of [3H]-Ins(1,3,4,5)P4 by alpha-trinositol yielded a K1 of 11 microM. The Ins(1,4,5)P3 receptor displayed an affinity of 15 nM in cerebellum and of 5 to 7 nM in the other tissues investigated. 4. The solubilized Ins(1,3,4,5)P4 receptor preparation from cerebellum did not show Ins(1,2,6)P3 binding. Ins(1,2,6)P3 binding was found in the pellet obtained after solubilization of the membranes with the detergent Brij 58. 5. Thus, in different tissues alpha-trinositol binds to proteins with different affinity. They are obviously not related to binding sites for Ins (1,4,5)P3 or for Ins(1,3,4,5)P4. Future experiments have to unravel the identity of the binding protein(s) for alpha-trinositol.

Citing Articles

Expression of ITPR2 regulated by lncRNA-NONMMUT020270.2 in LPS-stimulated HT22 cells.

Liu L, Tang L, Wang Y, Liu S, Zhang Y Heliyon. 2024; 10(13):e33491.

PMID: 39040287 PMC: 11260991. DOI: 10.1016/j.heliyon.2024.e33491.

References

Nicoletti F, Bruno V, Fiore L, Cavallaro S, Canonico P . Inositol hexakisphosphate (phytic acid) enhances Ca2+ influx and D-[3H]aspartate release in cultured cerebellar neurons. J Neurochem. 1989; 53(4):1026-30. DOI: 10.1111/j.1471-4159.1989.tb07390.x. View

Theibert A, Supattapone S, Worley P, Baraban J, Meek J, Snyder S . Demonstration of inositol 1,3,4,5-tetrakisphosphate receptor binding. Biochem Biophys Res Commun. 1987; 148(3):1283-9. DOI: 10.1016/s0006-291x(87)80272-3. View

Claxson A, Morris C, Blake D, SIREN M, Halliwell B, Gustafsson T . The anti-inflammatory effects of D-myo-inositol-1.2.6-trisphosphate (PP56) on animal models of inflammation. Agents Actions. 1990; 29(1-2):68-70. DOI: 10.1007/BF01964724. View

Donie F, Hulser E, Reiser G . High-affinity inositol 1,3,4,5-tetrakisphosphate receptor from cerebellum: solubilization, partial purification and characterization. FEBS Lett. 1990; 268(1):194-8. DOI: 10.1016/0014-5793(90)81006-a. View

Challiss R, Willcocks A, Mulloy B, Potter B, Nahorski S . Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochem J. 1991; 274 ( Pt 3):861-7. PMC: 1150196. DOI: 10.1042/bj2740861. View

Donie F, Reiser G . Purification of a high-affinity inositol 1,3,4,5-tetrakisphosphate receptor from brain. Biochem J. 1991; 275 ( Pt 2):453-7. PMC: 1150074. DOI: 10.1042/bj2750453. View

Reiser G, Schafer R, Donie F, Hulser E, Mayr G . A high-affinity inositol 1,3,4,5-tetrakisphosphate receptor protein from brain is specifically labelled by a newly synthesized photoaffinity analogue, N-(4-azidosalicyl)aminoethanol(1)-1-phospho-D-myo-inositol 3,4,5-trisphosphate. Biochem J. 1991; 280 ( Pt 2):533-9. PMC: 1130581. DOI: 10.1042/bj2800533. View

Regunathan S, Reis D, Wahlestedt C . Specific binding of inositol hexakisphosphate (phytic acid) to adrenal chromaffin cell membranes and effects on calcium-dependent catecholamine release. Biochem Pharmacol. 1992; 43(6):1331-6. DOI: 10.1016/0006-2952(92)90510-p. View

Theibert A, Estevez V, Mourey R, Marecek J, Barrow R, Prestwich G . Photoaffinity labeling and characterization of isolated inositol 1,3,4,5-tetrakisphosphate- and inositol hexakisphosphate-binding proteins. J Biol Chem. 1992; 267(13):9071-9. View

10.

Shears S . Metabolism of inositol phosphates. Adv Second Messenger Phosphoprotein Res. 1992; 26:63-92. View

11.

Potter E, Edvinsson L, Gustafsson T . Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog. Eur J Pharmacol. 1992; 221(2-3):307-14. DOI: 10.1016/0014-2999(92)90717-i. View

12.

Wahlestedt C, Reis D, Yoo H, Adamsson M, Andersson D, Edvinsson L . A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP). Neurosci Lett. 1992; 143(1-2):123-6. DOI: 10.1016/0304-3940(92)90247-5. View

13.

Cullen P, Irvine R . Inositol 1,3,4,5-tetrakisphosphate binding sites in neuronal and non-neuronal tissues. Properties, comparisons and potential physiological significance. Biochem J. 1992; 288 ( Pt 1):149-54. PMC: 1132092. DOI: 10.1042/bj2880149. View

14.

Berridge M . Inositol trisphosphate and calcium signalling. Nature. 1993; 361(6410):315-25. DOI: 10.1038/361315a0. View

15.

Joseph S, Samanta S . Detergent solubility of the inositol trisphosphate receptor in rat brain membranes. Evidence for association of the receptor with ankyrin. J Biol Chem. 1993; 268(9):6477-86. View

16.

Wahlestedt C, Reis D . Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?. Annu Rev Pharmacol Toxicol. 1993; 33:309-52. DOI: 10.1146/annurev.pa.33.040193.001521. View

17.

Zhang L, Bradley M, Khoyi M, Westfall D, Buxton I . Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in smooth muscle. Br J Pharmacol. 1993; 109(4):905-12. PMC: 2175757. DOI: 10.1111/j.1476-5381.1993.tb13706.x. View

18.

Nakazawa H, Gustafsson T, Traber L, Herndon D, Traber D . alpha-Trinositol decreases lung edema formation after smoke inhalation in an ovine model. J Appl Physiol (1985). 1994; 76(1):278-82. DOI: 10.1152/jappl.1994.76.1.278. View

19.

Lund T, Reed R . Alpha-Trinositol inhibits edema generation and albumin extravasation in thermally injured skin. J Trauma. 1994; 36(6):761-5. DOI: 10.1097/00005373-199406000-00001. View

20.

Yoo H, Fallgren B, Lindahl A, Wahlestedt C . Characterization of specific binding sites for alpha-trinositol (D-myo-inositol 1,2,6-trisphosphate) in rat tissues. Eur J Pharmacol. 1994; 268(1):55-63. DOI: 10.1016/0922-4106(94)90119-8. View